Literature DB >> 216532

The significance of a cytologically negative pleural effusion in bronchogenic carcinoma.

D A Decker, D E Dines, W S Payne, P E Bernatz, P C Pairolero.   

Abstract

Bronchogenic carcinoma complicated by ipsilateral cytologically positive effusion is considered unresectable. Bronchogenic carcinoma with cytologically negative effusion, even if bloody, has also been thought by many to be unresectable. Seventy-three patients with bronchogenic carcinoma and ipsilateral cytologically negative effusions were studied. Sixty-six underwent exploratory thoracotomy for staging or therapy; five had pleural biopsies and two had mediastinoscopies, all disclosing metastatic carcinoma. Four of the 73 patients (5.5 percent) had surgically resectable disease. They have remained free of disease for 3, 6, 7, and 14 years. Sixty-nine patients (94.5 percent) had unresectable carcinoma with metastases. Seventeen (94 percent) of 18 patients with bloody effusions had unresectable cancer. Carcinoma was resected in one patient with cytologically negative bloody effusion, and the patient remained free of disease during the 14-year follow-up period. Unresectability must be documented surgically in these patients to exclude those in whom curative resection can be performed.

Entities:  

Mesh:

Year:  1978        PMID: 216532     DOI: 10.1378/chest.74.6.640

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  [Video-assisted diagnostic thoracoscopy].

Authors:  T Bergmann; S Bölükbas; S Beqiri; J Schirren
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

2.  Predictive models of malignant transudative pleural effusions.

Authors:  Lucía Ferreiro; Francisco Gude; María E Toubes; Adriana Lama; Juan Suárez-Antelo; Esther San-José; Francisco Javier González-Barcala; Antonio Golpe; José M Álvarez-Dobaño; Carlos Rábade; Nuria Rodríguez-Núñez; Carla Díaz-Louzao; Luis Valdés
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

Review 3.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

Review 4.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

5.  Further experience of Corynebacterium parvum in malignant pleural effusion.

Authors:  D T McLeod; P M Calverley; J W Millar; N W Horne
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

6.  A Case of Pneumonia Masking Pleural Malignancy.

Authors:  Qian Xu; Juanjuan Tian; Lin Huang; Qilin Zhong; Yulin Xu; Linlin Liu; Jian Shi
Journal:  Onco Targets Ther       Date:  2022-07-02       Impact factor: 4.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.